Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2006 2
2007 1
2008 2
2009 1
2011 1
2012 1
2013 1
2015 1
2016 3
2017 1
2018 3
2019 2
2020 5
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

25 results
Results by year
Filters applied: . Clear all
Page 1
First-line R-CVP versus R-CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4.
Walewski J, Paszkiewicz-Kozik E, Michalski W, Rymkiewicz G, Szpila T, Butrym A, Giza A, Zaucha JM, Kalinka-Warzocha E, Wieczorkiewicz A, Zimowska-Curyło D, Knopińska-Posłuszny W, Tyczyńska A, Romejko-Jarosińska J, Dąbrowska-Iwanicka A, Gruszecka B, Jamrozek-Jedlińska M, Borawska A, Hołda W, Porowska A, Romanowicz A, Hellmann A, Stella-Hołowiecka B, Deptała A, Jurczak W. Walewski J, et al. Among authors: paszkiewicz kozik e. Br J Haematol. 2020 Mar;188(6):898-906. doi: 10.1111/bjh.16264. Epub 2019 Dec 2. Br J Haematol. 2020. PMID: 31792945 Free PMC article. Clinical Trial.
EZH2 Expression in Follicular Lymphoma Is Variable and Independent from the Progression of Disease Within 24 Months of First Treatment.
Szumera-CieĆkiewicz A, Poleszczuk J, Paszkiewicz-Kozik E, Rymkiewicz G, SokÓŁ K, Borysiuk A, Kotarska M, Owczarek D, Kawecka M, Pytlak B, Walewski J, Prochorec-Sobieszek M. Szumera-CieĆkiewicz A, et al. Among authors: paszkiewicz kozik e. Anticancer Res. 2020 Dec;40(12):6685-6697. doi: 10.21873/anticanres.14692. Anticancer Res. 2020. PMID: 33288562
PD1 distribution pattern, regardless of the cell origin, is an independent microenvironmental prognostic factor for progression-free survival in follicular lymphoma.
Szumera-Ciećkiewicz A, Poleszczuk J, Kuczkiewicz-Siemion O, Paszkiewicz-Kozik E, Rymkiewicz G, Sokół K, Borysiuk A, Kotarska M, Kawecka M, Owczarek D, Pytlak B, Walewski J, Prochorec-Sobieszek M. Szumera-Ciećkiewicz A, et al. Among authors: paszkiewicz kozik e. Pathol Res Pract. 2020 Oct;216(10):153096. doi: 10.1016/j.prp.2020.153096. Epub 2020 Jun 29. Pathol Res Pract. 2020. PMID: 32853965
Significance of CD10 protein expression in the diagnostics of follicular lymphoma: A comparison of conventional immunohistochemistry with flow cytometry supported by the establishment of BCL2 and BCL6 rearrangements.
Szumera-Ciećkiewicz A, Rymkiewicz G, Sokół K, Paszkiewicz-Kozik E, Borysiuk A, Poleszczuk J, Bachnio K, Bystydzienski Z, Woroniecka R, Grygalewicz B, Kotarska M, Stańczak M, Owczarek D, Pytlak B, Prochorec-Sobieszek M, Walewski J. Szumera-Ciećkiewicz A, et al. Among authors: paszkiewicz kozik e. Int J Lab Hematol. 2020 Aug;42(4):453-463. doi: 10.1111/ijlh.13222. Epub 2020 May 4. Int J Lab Hematol. 2020. PMID: 32364682
Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis.
Federico M, Caballero Barrigón MD, Marcheselli L, Tarantino V, Manni M, Sarkozy C, Alonso-Álvarez S, Wondergem M, Cartron G, Lopez-Guillermo A, Issa D, Morschhauser F, Alcoceba M, Kimby E, Rusconi C, Chamuleau M, Holte H, Lockmer S, Montoto S, Gomes da Silva M, Aurer I, Zucca E, Paszkiewicz-Kozik E, Minoia C, Skrypets T, Blaker YN, Salles G, Coiffier B; Aristotle Consortium. Federico M, et al. Among authors: paszkiewicz kozik e. Lancet Haematol. 2018 Aug;5(8):e359-e367. doi: 10.1016/S2352-3026(18)30090-5. Epub 2018 Jul 4. Lancet Haematol. 2018. PMID: 30078408
Human regulatory T cells suppress proliferation of B lymphoma cells.
Grygorowicz MA, Biernacka M, Bujko M, Nowak E, Rymkiewicz G, Paszkiewicz-Kozik E, Borycka IS, Bystydzienski Z, Walewski J, Markowicz S. Grygorowicz MA, et al. Among authors: paszkiewicz kozik e. Leuk Lymphoma. 2016 Aug;57(8):1903-20. doi: 10.3109/10428194.2015.1121260. Epub 2016 Jan 12. Leuk Lymphoma. 2016. PMID: 26758248
Prospective study of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma patients who are not suitable for stem cell transplant or multi-agent chemotherapy.
Walewski J, Hellmann A, Siritanaratkul N, Ozsan GH, Ozcan M, Chuncharunee S, Goh AS, Jurczak W, Koren J, Paszkiewicz-Kozik E, Wang B, Singh S, Huebner D, Engert A, von Tresckow B. Walewski J, et al. Among authors: paszkiewicz kozik e. Br J Haematol. 2018 Nov;183(3):400-410. doi: 10.1111/bjh.15539. Epub 2018 Aug 30. Br J Haematol. 2018. PMID: 30168134 Clinical Trial.
25 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page